Provided by Tiger Trade Technology Pte. Ltd.

AC Immune SA

2.65
+0.00500.19%
Volume:43.90K
Turnover:115.86K
Market Cap:269.19M
PE:-5.03
High:2.68
Open:2.62
Low:2.58
Close:2.64
52wk High:4.00
52wk Low:2.04
Shares:101.77M
Float Shares:39.19M
Volume Ratio:0.40
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5264
EPS(LYR):-0.8828
ROE:-78.53%
ROA:-16.04%
PB:6.22
PE(LYR):-3.00

Loading ...

AC Immune IFRS Net Loss Narrows to CHF 12.93 Million in H1 FY26; Revenue Rises to CHF 16.23 Million

Reuters
·
Aug 05

AC Immune - Reports H1 2026 Revenue of CHF 16.20 Mln

THOMSON REUTERS
·
Aug 05

AC Immune First Half 2026 Financial and Corporate Update

THOMSON REUTERS
·
Aug 05

AC Immune - Reports Cash Resources of CHF 75.40 Mln as of June 30, 2026

THOMSON REUTERS
·
Aug 05

Swiss Stocks - Factors to Watch on August 3

Reuters
·
Aug 03

AC Immune to Present Early Human Data for First-in-class Tdp-43 PET Tracer at AAIC 2026

Reuters
·
Jul 07

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

GlobeNewswire
·
Jul 07

AC Immune Says Antibody Responses Detected in Phase 1b/2 Trial of ACI-24 in Alzheimer's Disease

MT Newswires Live
·
Jun 30

AC Immune - Aci-24 Generally Safe and Well Tolerated with no Aria-e Observed to Date

THOMSON REUTERS
·
Jun 30

AC Immune Reports Interim 12-month Data from Phase 1B/2 Abate Trial of Aci-24 in Prodromal Alzheimer’s Disease

THOMSON REUTERS
·
Jun 30

AC Immune - Final Data From Part 1 of Vacsyn Trial Expected in H2 2026

THOMSON REUTERS
·
Jun 11

AC Immune - Planned Extension to Assess Long-Term Safety and Efficacy of ACI-7104 for 2 Years

THOMSON REUTERS
·
Jun 11

Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease

Dow Jones
·
Jun 11

AC Immune Phase 1 data show higher ACI-19626 TDP-43 PET uptake in ALS brains

Reuters
·
May 22

Top Executive Move at AC Immune SA Sparks Fresh Investor Buzz

TIPRANKS
·
May 19

AC Immune CEO Andrea Pfeifer sells 10,000 shares worth $27,940

Reuters
·
May 19

AC Immune CEO Pfeifer retires; Chair Zügel becomes interim CEO

Reuters
·
May 12

AC Immune Announces Retirement of CEO DR Andrea Pfeifer at Upcoming AGM

THOMSON REUTERS
·
May 12

AC Immune Sa - Appoints Martin ZÜGel as Interim CEO

THOMSON REUTERS
·
May 12

AC Immune Price Target Maintained With a $8.00/Share by BTIG

Dow Jones
·
May 04